Kentucky Revised Statutes Title XVIII. Public Health § 217.5401.Definitions for KRS 217.5401 to 217.5408

(1) “Biological product” means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, protein other than a chemically synthesized polypeptide, allergenic product or analogous product, or arsphenamine or derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings;

(2) “Device” has the same meaning as in KRS 217.015;

(3) “Drug” has the same meaning as in KRS 217.015;

(4) “Eligible patient” means an individual who meets the requirements of KRS 217.5403;

(5) “Health care provider” means a licensed physician, a licensed advanced practice registered nurse, or a licensed physician assistant;

(6) “Health facility” has the same meaning as in KRS 216B.015;

(7) “Investigational drug, biological product, or device” means a drug, biological product, or device that:

(8) “Terminal illness” means a progressive disease or a medical or surgical condition that:

(9) “Written informed consent” means a written document that meets the requirements of KRS 217.5407.